Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Acadia Healthcare Company Inc (ACHC) vs Enovix Corporation (ENVX) Price & Performance

Acadia Healthcare Company IncTrade
Enovix CorporationTrade

Price performance (Past 24H)

Key statistics

Acadia Healthcare Company Inc vs Enovix Corporation — how do they compare? Acadia Healthcare Company Inc trades at $31.18 (market cap $2.96B), while Enovix Corporation trades at $4.86 (market cap $1.01B). The key difference: Acadia Healthcare Company Inc is far larger — about 2.9× Enovix Corporation's market cap, and Acadia Healthcare Company Inc is trading nearer its 52-week high, Enovix Corporation nearer its low. Which is the better fit depends on your goals.

ACHCENVX
Market Cap
$2.96B$1.01B
Sector
HealthTechnology
52-Week High
$35.61$13.19
52-Week Low
$11.68$3.68
Enterprise Value
$5.35B$1.03B

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Acadia Healthcare Company Inc

ACHC trades at $31.53, up 2.64% today, with a neutral technical signal despite bullish moving averages. The company shows strong revenue growth with Q2 2026 earnings beating estimates, but faces profitability challenges with negative net income margins. Analyst consensus remains positive with 68% buy ratings and a $36 price target, though ongoing legal investigations create headwinds.

The outlook balances operational strength against financial risks. Revenue growth and facility expansion support upside potential, but negative profitability and legal uncertainties warrant caution. The stock offers 14% upside to consensus target if execution improves, but investors should monitor earnings sustainability and legal developments closely.

Enovix Corporation

ENVX trades at $4.70, up 10.33% today, with a bullish technical signal despite negative profitability. Recent earnings beats and a $12.38 consensus price target suggest upside potential. The company is ramping production of advanced silicon-anode batteries, with key developments including a new COO appointment and upcoming Q2 2026 results on August 12, 2026.

Outlook remains speculative with high revenue growth potential but persistent losses; risks include cash burn and competitive pressures. Analyst sentiment is positive (75% buy ratings), but investors should weigh the long-term growth story against near-term financial challenges.

Returns comparison

Trailing returns across standard periods

About Acadia Healthcare Company Inc

Acadia Healthcare is a leading provider of behavioral healthcare services across the US and Puerto Rico. It operates a network of psychiatric hospitals, residential treatment centers, and clinics for mental health and addiction recovery.

Read more on ACHC

About Enovix Corporation

Enovix designs and manufactures advanced silicon-anode lithium-ion batteries. Its technology aims to provide high energy density and improved performance for mobile devices and consumer electronics.

Read more on ENVX